Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Nextech Invest is a biotechnology investment firm based in Zurich, Switzerland, specializing in precision medicine and cancer therapies. The firm invests globally across various stages, including pre-seed to Series C, and has a portfolio of five companies. Their approach combines scientific validation with active support during critical development phases.
Nextech Invest focuses on biotechnology companies that are developing innovative cancer medicines. They invest in early-stage to growth-stage companies, emphasizing scientific validation and hands-on support. The firm seeks first and best-in-class targeted therapies in the precision medicine sector.
Nextech Invest's portfolio includes notable companies such as A2 Biotherapeutics, which develops novel medicines for serious illnesses; AiRNA, focused on RNA-editing medicines for alpha-1 antitrypsin deficiency; Alpha-9 Oncology, a clinical-stage company working on imaging and therapeutic molecules; Alterome Therapeutics, dedicated to precision oncology; and Alumis, which aims to improve outcomes in immune-mediated diseases.
Nextech Invest invests in companies at various stages, from pre-seed to Series C.
The firm specializes in biotechnology, particularly in precision medicine and cancer therapies.
Nextech Invest provides hands-on support during critical development phases, emphasizing scientific validation.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.